Autolus Therapeutics (AUTL) Total Debt (2017 - 2019)

Autolus Therapeutics' (AUTL) quarterly Total Debt came in at $30000.0 in Q3 2019, down 92.11% YoY from $380000.0 in Q3 2018, and down 75.21% on a QoQ basis from $121000.0 in Q2 2019.

Autolus Therapeutics (AUTL) Total Debt (2017 - 2019) Analysis & Trends

Autolus Therapeutics (AUTL) has 3 years of Total Debt data on file, last reported at $30000.0 in Q3 2019.

  • Quarterly Total Debt fell 92.11% year-over-year to $30000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $30000.0 (down 92.11% YoY) and the FY2019 annual result came in at $30000.0, down 92.11% from the prior year.
  • Total Debt eased to $30000.0 in Q3 2019, from $121000.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $763000.0 in Q3 2017 to a low of $30000.0 in Q3 2019.
  • A 3-year average of $315800.0 and a median of $285000.0 in 2018 frame the typical range for Total Debt.
  • Annual changes were most pronounced in 2018 — Total Debt plunged 50.2% — and 2019, when it tumbled 92.11%.
  • Tracing AUTL's Total Debt over 3 years: stood at $763000.0 in 2017, then tumbled by 62.65% to $285000.0 in 2018, then tumbled by 89.47% to $30000.0 in 2019.
  • The last three Total Debt figures came in at $30000.0 (Q3 2019), $121000.0 (Q2 2019), and $285000.0 (Q4 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.07 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 9.34 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 546.77 Mn
10 Autolus Therapeutics 763.37 Mn 561.74 Mn 25.22 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2019 30,000.00
Jun 30, 2019 121,000.00
Dec 31, 2018 285,000.00
Sep 30, 2018 380,000.00
Sep 30, 2017 763,000.00